Jerusalem artichoke and chungkookjang additively improve insulin secretion and sensitivity in diabetic rats

Nutrition and Metabolism

Volumn 9, Issue , 2012, Pages

  Yang, Hye Jeong ^a   Kwon, Dae Young ^a   Kim, Min Jung ^a   Kang, Suna ^b   Kim, Da Sol ^b   Park, Sunmin ^b  

^a Korea Food Research Institute   (South Korea)

^b Hoseo University   (South Korea)

Author keywords

Chungkookjang; Insulin resistance; Insulin secretion; Islet morphometry; Jerusalem artichokes

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; AGLYCONE; ANTIDIABETIC AGENT; CASEIN; CHUNGKOOKJANG EXTRACT; DAIDZEIN; DAIDZIN; GENISTEIN; GENISTIN; GLUCOSE; GLYCOSIDE; INSULIN; INSULIN RECEPTOR SUBSTRATE 2; ISOFLAVONOID; JERUSALEM ARTICHOKE EXTRACT; LEPTIN; PLANT EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; APOPTOSIS; AREA UNDER THE CURVE; ARTICLE; BIOACCUMULATION; CALORIC INTAKE; CELL PROLIFERATION; CELL SURVIVAL; CHUNGKOOKJANG; CONTROLLED STUDY; EPIDIDYMIS FAT; FOOD INTAKE; GLUCOSE INFUSION; GLUCOSE TOLERANCE; HYPERINSULINEMIA; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; JERUSALEM ARTICHOKE; LIPID DIET; MALE; MEDICINAL PLANT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ANIMALIA; GLYCINE MAX; HELIANTHUS TUBEROSUS; RATTUS;

EID: 84871591885     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-9-112     Document Type: Article

References (38)

1. The division of National Nutrition Survey, 1993 National nutrition survey report in Korea Seoul: Ministry of Health and Welfare 1996
2. Early life origins of insulin resistance and type 2 diabetes in India and other Asian countries. Yajnik CS, J Nutr 2004 134 205 210 14704320 (Pubitemid 38057450)
3. Type 2 diabetes prevalence in Asian Americans: results of a national health survey. McNeely MJ, Boyko EJ, Diabetes Care 2004 27 66 69 10.2337/diacare.27.1.66 14693968 (Pubitemid 38196711)
4. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, Hu FB, JAMA 2009 301 2129 2140 10.1001/jama.2009.726 19470990
5. Pathogenesis of NIDDM: A balanced overview. DeFronzo RA, Bonadonna RC, Ferrannini E, Diabetes Care 1992 15 318 353 10.2337/diacare.15.3.318 1532777
6. Long-term consumption of fermented soybean-derived Chungkookjang enhances insulinotropic action unlike soybeans in 90% pancreatectomized diabetic rats. Kwon DY, Jang JS, Hong SM, Lee JE, Sung SR, Park HR, Park S, Eur J Nutr 2007 46 44 52 10.1007/s00394-006-0630-y 17200876 (Pubitemid 46208260)
7. Long-term consumption of fermented soybean-derived Chungkookjang attenuates hepatic insulin resistance in 90% pancreatectomized diabetic rats. Kwon DY, Hong SM, Lee JE, Sung SR, Park S, Horm Metab Res 2007 39 752 757 10.1055/s-2007-990287 17952839 (Pubitemid 350099825)
8. Applications of inulin and oligofructose in health and nutrition. Kaur N, Gupta AK, J Biosci 2002 27 703 714 10.1007/BF02708379 12571376 (Pubitemid 36091305)
9. Effect of dietary propionate on hepatic glucose production, whole body glucose utilization, carbohydrate and lipid metabolism in normal rats. Boillot J, Alamowitch C, Berger AM, Luo J, Bruzzo F, Br J Nutr 1995 73 241 255 10.1079/BJN19950026 7718543
10. Chronic consumption of short chain fructooligosaccharides by healthy subjects decreased basal hepatic glucose production but had no effect on insulin-stimulated glucose metabolism. Luo J, Rizkalla SW, Alamovitch C, Boussairi A, Blayo A, Am J Clin Nutr 1996 63 639 645
11. Change of isoflavone content during manufacturing of Cheonggukjang, a traditional Korean fermented soyfood. Jang CH, Lim JK, Kim JH, Park CS, Kwon DY, Kim YS, Kim JS, Food Sci Biotech 2006 15 643 646
12. Correlation between antioxidative activities and metabolite changes during Cheonggukjang fermentation. Kim J, Choi JN, Kang D, Son GH, Kim YS, Choi HK, Kwon DY, Lee CH, Biosci Biotech Biochemy 2011 75 732 739 10.1271/bbb.100858
13. A photometric ninhydrin method for the measurement of proteolysis. Schwartz TB, Engel FL, J Biol Chem 1950 184 197 202 15421989
14. Mechanism of impaired glucose-potentiated insulin secretion in diabetic 90% pancreatectomy rats. Study using glucagons like peptide-1(7-37). Hosokawa YA, Hosokawa H, Chen C, Leahy JL, J Clin Invest 1996 97 180 186 10.1172/JCI118387 8550831 (Pubitemid 26022593)
15. Effect of in vivo vanadate treatment on insulin receptor tyrosine kinase activity in partially pancreatectomized diabetic rats. Cordera R, Andraghetti G, DeFronzo RA, Rossetti L, Endocrinology 1990 126 2177 2183 10.1210/endo-126-4- 2177 2156685 (Pubitemid 20139769)
16. Estrogen and exercise may enhance β-cell function and mass via IRS2 induction in ovariectomized diabetic rats. Choi SB, Jang JS, Park S, Endocrinology 2005 146 4786 4794 10.1210/en.2004-1653 16037383 (Pubitemid 41446616)
17. Ad Hoc committee on standards for nutritional studies. Report of the American Institute of Nutrition, J Nutr 1997 107 1340 1348
18. The composition of dietary fat directly influences glucose-stimulated insulin secretion in rats. Dobbins RL, Szczepaniak LS, Myhill J, Tamura Y, Uchino H, Giacca A, McGarry JD, Diabetes 2002 51 1825 1833 10.2337/diabetes.51. 6.1825 12031970 (Pubitemid 34564295)
19. Prevention of fat-induced insulin resistance by salicylate. Kim JK, Kim YJ, Fillmore JJ, Chen Y, Moore I, Lee J, Yuan M, Li ZW, Karin M, Perret P, Shoelson SE, Shulman GI, J Clin Invest 2001 108 437 446 11489937 (Pubitemid 32730790)
20. Gastrin stimulates β-cell neogenesis and increases islet mass from transdifferentiated but not from normal exocrine pancreas tissue. Rooman I, Lardon J, Bouwen L, Diabetes 2002 51 686 690 10.2337/diabetes.51.3.686 11872667 (Pubitemid 34760176)
21. In vivo insulin resistance induced by amylin primarily through inhibition of insulin-stimulated glycogen synthesis in skeletal muscle. Frontoni S, Choi SB, Banduch D, Rossetti L, Diabetes 1991 40 568 573 10.2337/diabetes.40.5.568 2022302
22. Muscle GLUT 4 protein levels and impaired triglyceride metabolism in streptozotocin diabetic rats. Effect of a high sucrose diet and fish oil supplementation. Sebokova E, Klimes I, Moss R, Stolba P, Wiersma MM, Mitkova A, Ann NY Acad Sci 1993 683 218 227 10.1111/j.1749-6632.1993.tb35710.x 8102516 (Pubitemid 23236671)
23. Effects of dietary inulin, statin, and their co-treatment on hyperlipidemia, hepatic steatosis and changes in drug-metabolizing enzymes in rats fed a high-fat and high-sucrose diet. Sugatani J, Sadamitsu S, Wada T, Yamazaki Y, Ikari A, Miwa M, Nutr Metab 2012 9 23 10.1186/1743-7075-9-23
24. Effect of fructooligosaccharides on blood glucose and serum lipids in diabetic subjects. Yamashita K, Kawai K, Itakurqa K, Nutr Res 1984 4 961 966 10.1016/S0271-5317(84)80075-5 (Pubitemid 15177328)
25. Hypoglycemic activity and antioxidant potential of some medicinal plants traditionally used in Turkey for diabetes. Aslan M, Orhan N, Orhan DD, Ergun F, J Ethnopharmacol 2010 128 384 389 10.1016/j.jep.2010.01.040 20100559
26. Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARγ-related adipogenesis in the white adipose tissue of high-fat diet-fed mice. Dewulf EM, Cani PD, Neyrinck AM, Possemiers S, Van Holle A, Muccioli GG, Deldicque L, Bindels LB, Pachikian BD, Sohet FM, Mignolet E, Francaux M, Larondelle Y, Delzenne NM, J Nutr Biochem 2011 22 712 722 10.1016/j.jnutbio.2010.05.009 21115338
27. Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Dewulf EM, Cani PD, Claus SP, Fuentes S, Puylaert PG, Neyrinck AM, Bindels LB, de Vos WM, Gibson GR, Thissen JP, Delzenne NM, Gut 2012 Epub ahead of print
28. Changes in soluble neutral carbohydrates composition of Jerusalem artichoke (Helianthus tuberosus Linne) tubers according to harvest date and storage temperature. Kang SI, Han JI, Kim KY, Oh SU, Kim SI, J Kr Agric Chem Soc 1993 36 304 309
29. Effect of planting date and cutting management on Jerusalem artichoke (Helianthus tuberosus Linne). Lim KB, Lee HJ, J Kr Grassl Sci 1983 4 147 151
30. Dietary fiber, inulin and oligofructose: a review comparing their physiological effects. Roberfroid M, Crit Rev Food Sci Nutr 1993 33 103 148 10.1080/10408399309527616 8257475
31. Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Parnell JA, Reimer RA, Am J Clin Nutr 2009 89 1751 1759 10.3945/ajcn.2009.27465 19386741
32. Biological actions and therapeutic potential of the glucagon-like peptides. Drucker DJ, Gastroenterology 2002 122 531 544 10.1053/gast.2002.31068 11832466 (Pubitemid 34117003)
33. Exendin-4 and exercise promotes β-cell function and mass through IRS2 induction in islets of diabetic rats. Park S, Hong SM, Sung SR, Life Sci 2008 82 503 511 10.1016/j.lfs.2007.12.018 18237751
34. Isoflavonoids and peptides from Meju, a long-term fermented soy food, increase insulin sensitivity and exert insulinotropic effects in vitro. Kwon DY, Hong SM, Ahn IS, Kim MJ, Yang HJ, Park S, Nutrition 2011 27 244 252 10.1016/j.nut.2010.02.004 20541368
35. Genistein induces pancreatic beta-cell proliferation through activation of multiple signaling pathways and prevents insulin-deficient diabetes in mice. Fu Z, Zhang W, Zhen W, Lum H, Nadler J, Bassaganya-Riera J, Jia Z, Wang Y, Misra H, Liu D, Endocrinology 2010 151 3026 3037 10.1210/en.2009-1294 20484465
36. Dietary soy protein isolate attenuates metabolic syndrome in rats via effects on PPAR, LXR, and SREBP signaling. Ronis MJ, Chen Y, Badeaux J, Badger TM, J Nutr 2009 139 1431 1438 10.3945/jn.109.107029 19515742
37. Consumption, perceptions and knowledge of soy among adults with type 2 diabetes. Gobert CP, Duncan AM, J Am Coll Nutr 2009 28 203 218 19828906
38. The isoflavonoid aglycone-rich fractions of Chungkookjang, fermented unsalted soybeans, enhance insulin signaling and peroxisome proliferator- activated receptor-γ activity in vitro. Kwon DY, Jang JS, Lee JE, Kim YS, Shin DW, Park S, Biofactors 2006 26 245 258 10.1002/biof.5520260403 17119271 (Pubitemid 44763977)